Compare Amphastar Pharmaceuticals Inc (AMPH) vs Roundhill NVDA WeeklyPay ETF (NVDW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amphastar Pharmaceuticals Inc vs Roundhill NVDA WeeklyPay ETF — how do they compare? Amphastar Pharmaceuticals Inc trades at $20.39 (market cap $863.95M), while Roundhill NVDA WeeklyPay ETF trades at $37.67. Which is the better fit depends on your goals.
| AMPH | NVDW | |
|---|---|---|
Market Cap | $863.95M | — |
Sector | Health | Income / Options Overlay |
52-Week High | $30.81 | $52.59 |
52-Week Low | $16.87 | $31.88 |
Enterprise Value | $1.26B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMPH trades at $20.78, up 4.9% today, with a bullish technical signal supported by moving averages. The stock shows mixed earnings performance with Q2 2026 beating estimates but Q1 and Q4 2025 missing. Fundamentals remain solid with a 10.76% net margin and reasonable valuation at 12.02 P/E. Recent news highlights Q2 2026 results and strategic shift toward proprietary drugs.
Outlook is cautiously optimistic with growth supported by new product launches, though regulatory risks and earnings volatility pose challenges. Analyst sentiment is mixed with 25% buy ratings but majority hold recommendations. The stock offers value but requires monitoring of FDA developments and earnings consistency.
NVDW, the Roundhill NVDA WeeklyPay ETF, trades at $38.845, up 2.47% today, with a bullish technical signal from moving averages. It provides a synthetic leveraged position in Nvidia with a variable income stream, highlighted by frequent dividend distributions. Recent coverage from Seeking Alpha on July 9, 2026, notes its high trailing yield potential but fluctuating payouts, positioning it as a cash-generating hedge for Nvidia exposure.
The outlook hinges on Nvidia's performance, offering income opportunities through dividends but with volatility risks due to payout fluctuations. Key risks include dependency on Nvidia's stock and market sentiment shifts, requiring careful assessment for income-focused investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →About Roundhill NVDA WeeklyPay ETF
NVDW is an actively managed ETF that seeks to provide weekly distributions and returns equal to 1.2 times (120%) the calendar week performance of Nvidia (NVDA) common shares. It combines modest leverage with a high-frequency payout schedule, designed for investors who want amplified exposure to Nvidia alongside a consistent weekly income stream.
Read more on NVDW →
